anti-IL-17 antibody therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for anti-IL-17 antibody therapy, covering 2025-05-09 to 2025-05-09. Get the full timeline:
Most recent: Clinical Trial Update: Optimizing Anti-IL17 Antibody Therapy by Associating Fiber Supplementation to Correct Treatment-aggravated Gut Dysbiosis in Axial Spondyloarthritis - RESPOND-IL17 [NA]